Popular Searches
New Pneumonia Treatment Study
This clinical trial explores if adding melatonin to standard pneumonia treatment can help children recover more quickly and spend less time in the hospital.
Clinical trials are essential to finding better treatments and improving health outcomes. This spotlight focuses on the Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia trial (NCT06949904). This study aims to explore how melatonin, a natural hormone, might help children with pneumonia recover faster when added to standard treatments.
Understanding new research is a top priority for patients and caregivers seeking information on treatment options, managing side effects, and exploring potential avenues for improvement. This post aims to provide a clear overview of what this trial is about and how it could potentially impact the future of Pneumonia Childhood care.
Pneumonia is a common lung infection in children that causes inflammation and makes it hard to breathe. Despite existing treatments like antibiotics, pneumonia can still cause long hospital stays and serious illness in some kids. The Melatonin Pneumonia Trial is exploring if adding melatonin, which has properties that might help the body heal, can shorten hospital stays and improve recovery. Recognizing pneumonia symptoms early helps ensure children get the care they need promptly.
centerwatch.com: This ongoing clinical trial is testing if giving children with pneumonia extra melatonin, along with their regular antibiotics, can help them recover faster and shorten their hospital stay. The trial includes kids from 1 month to 12 years old and compares those getting melatonin for 14 days plus regular treatment to those only getting regular treatment. [1].
journals.lww.com: This study looked at children with sepsis (a serious infection), and found that melatonin, when added to usual antibiotics, helped lower specific inflammation levels in the blood (IL-6 and IL-8) and led to better health outcomes compared to antibiotics alone. [2].
Pneumonia Childhood can manifest in various ways, but some of the most common symptoms include:
These symptoms can make it hard for children to play, eat, and breathe comfortably. Treating pneumonia effectively is important to help children feel better and avoid complications, which is why research like the Melatonin Pneumonia Trial is crucial.
The Melatonin Pneumonia Trial is testing whether melatonin, given along with the usual antibiotic treatment, can help children with pneumonia get better faster.
Melatonin is a natural substance your body makes to help control sleep and support the immune system. In this study, doctors are seeing if giving melatonin as a medicine helps children’s lungs heal faster when fighting pneumonia.
This study is designed to find out if melatonin added to standard antibiotics is safe and helps reduce the number of days children stay in the hospital with pneumonia.
Melatonin works as an antioxidant, which means it helps protect the body's cells from damage during infections. It also helps improve the body's natural defenses and may reduce inflammation in the lungs, potentially helping children recover faster from pneumonia.
Giving melatonin as an extra treatment might shorten hospital stays by helping the body heal more quickly, which can improve comfort and reduce medical costs for families.
This study randomly assigns children to either standard treatment alone or standard treatment plus melatonin. Neither the families, doctors, nor study assessors know who gets melatonin, ensuring the study is fair and the results reliable.
The Melatonin Pneumonia Trial embodies this crucial role in research, offering a potential path to:
Clinical trials have specific criteria to ensure the safety of participants and the validity of the study results. For the Melatonin Pneumonia Trial trial, key eligibility criteria include:
If you join the Melatonin Pneumonia Trial, here is what you can expect:
The duration of your participation will vary depending on the study design, but the research team will explain the full commitment before enrollment.
Like all medical interventions, participation in a clinical trial carries both potential benefits and risks.
A detailed explanation of all potential risks and benefits will be provided during the informed consent process.
The Melatonin Pneumonia Trial (NCT06949904) is currently recruiting patients at Pakistan Institute of Medical Sciences in Islamabad, Pakistan.
If you are interested in potentially participating, it is crucial to discuss these criteria with your healthcare provider. They can determine if you meet the specific requirements. You may share this link with your provider’s email address, or have them visit ClinQuestAi.com and type in NCT06949904.
You can also:
Remember: Deciding to participate in a clinical trial is a personal choice. It’s important to discuss all aspects of the trial with your healthcare provider to ensure it’s the right decision for your individual health situation.
All health-related content on this website, whether drafted by our team or with AI assistance, undergoes a rigorous human review process before publication. Every article is fact-checked, edited, and medically reviewed by a licensed medical professional with relevant expertise. Our goal is to provide information that is accurate, aligned with current medical consensus, empathetic, and useful for patients and caregivers. We are committed to transparency, clearly citing sources and displaying author and reviewer credentials to uphold the highest standards of E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness).